NasdaqHealth CareBiological Products, (No Diagnostic Substances)OAKVILLE, Ontario, Canada

Cardiol Therapeutics Inc. CRDL

Ask your AI

Estimated market cap $100.26M100.26M shares, shares as of Dec 31, 2025CIK 1702123

Insider trades, 12 mo

—

No open-market trades

Congress trades, 24 mo

—

No disclosed trades

13F holders, Q3 2026

9 added · 6 trimmed

13F holders

…

Lobbying, 12 mo

—

No lobbying filings

Federal contracts, 12 mo

—

None matched

Ask your AI:

Latest 10-Q

What changed in Cardiol Therapeutics Inc.'s latest quarterly report, compared with the one before.

We have not read a recent 10-Q for this company yet.

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

No recent insider purchases or sales for this company.

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

Loading…

13F holders

25.80M shares

40 funds report CRDL. Values checked against market prices.

Funds own 29% of shares (Q2 2026)

52 funds hold the stock.

Q3 2026: 26% · 5,560 of ~8,900 funds reported so far

Q2 20257.9%
Q3 20257.3%
Q4 20259.1%
Q1 202628%
Q2 202629%
Q3 2026 (so far)26%

Q3 2026. 8 new, 9 added to, 6 trimmed, 20 exited since Q2 2026.

Top 13F holders
#
1	Mmcap International Inc. SPC 13F ↗	15.60M	$25.9M	unchanged
2	Tejara Capital Ltd 13F ↗	7.42M	$12.3M	+45.1%
3	Morgan Stanley 13F ↗	1.01M	$1.7M	+184.7%
4	Integrity Alliance, LLC 13F ↗	310,896	$516.1K	-20.0%
5	Jane Street Group, LLC 13F ↗	152,876	$254.6K	+186.2%
6	HRT Financial LP 13F ↗	130,612	$216.0K	n/a
7	MGO One Seven LLC 13F ↗	100,000	$166.0K	unchanged
8	1832 Asset Management L.P. 13F ↗	100,000	$166.0K	unchanged
9	AIGH Capital Management LLC 13F ↗	100,000	$166.0K	New
10	Birchview Capital, LP 13F ↗	100,000	$166.0K	New

One of these funds reports its values in thousands of dollars; its figures are shown in dollars.

Download CSV Every fund that holds CRDL, not only these ten. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

13F holders

Funds that report this stock, checked against market prices.

Loading…

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

No recent congressional trades for this company.

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

Loading…

Lobbying

What Cardiol Therapeutics Inc. and its lobbying firms report each quarter.

No recent lobbying filings for this company.

Lobbying

What Cardiol Therapeutics Inc. and its lobbying firms report each quarter.

Loading…

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Funds holding the stock

Shares they report

Funds holding the stock by quarter

Q4 2019	1	—	192,680	$681.0K
Q1 2020	1	0	210,470	$600.0K
Q2 2020	1	0	243,504	$577.0K
Q3 2020	1	0	287,106	$876.0K
Q4 2020	1	0	348,769	$970.0K
Q3 2021	19	+18	1.61M	$6.6M
Q4 2021	33	+14	5.80M	$10.7M
Q1 2022	28	-5	5.39M	$8.3M
Q2 2022	27	-1	5.30M	$7.0M
Q3 2022	26	-1	4.77M	$4.9M
Q4 2022	32	+6	6.77M	$3.6M
Q1 2023	35	+3	7.25M	$3.5M
Q2 2023	33	-2	6.69M	$6.0M
Q3 2023	35	+2	6.37M	$5.8M
Q4 2023	32	-3	6.92M	$6.0M
Q1 2024	35	+3	6.55M	$11.7M
Q2 2024	41	+6	5.39M	$10.8M
Q3 2024	41	0	4.98M	$9.9M
Q4 2024	43	+2	7.49M	$9.6M
Q1 2025	38	-5	7.72M	$7.4M
Q2 2025	38	0	6.49M	$8.8M
Q3 2025	48	+10	7.30M	$7.8M
Q4 2025	41	-7	9.10M	$8.7M
Q1 2026	47	+6	27.88M	$37.6M
Q2 2026	52	+5	29.48M	$31.3M
Q3 2026	40	-12	25.80M	$42.8M

Each point is a quarter-end, from Q4 2019 to Q3 2026. A fund's 13F lists its long positions in US-listed securities as of the last day of the quarter and arrives up to 45 days later, so each point shows holdings at quarter-end, not on the day they were reported.

Common shares only; options and bonds are left out. When a fund amends a report, the amended version is the one counted.

The history follows the company's current CUSIP number (14161Y200). If the company's shares were ever re-issued under a different CUSIP, the quarters before the change are not part of this series, so the first point (Q4 2019) can be later than the stock's first appearance in 13F reports.

Share counts are adjusted for stock splits; none took place between these quarters. Values are in dollars as reported at the time and are not adjusted.

A quarter appears once our daily update has built its summary. If a summary cannot be built, older reports are kept and the chart shows the quarters it has until the next update repairs it.

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Loading…

More filings and data

Each opens the table.

Ownership stakes4 in 12 mo 8-K eventsNone in 90 days Patents2 patents granted Short interestFINRA · updated Oct 15 Planned insider salesNone in 12 mo Executive payNone on record Wikipedia attentionNone on record SEC enforcementNone on record Clinical trials1 active Ownership stakes…8-K events…Patents…Short interest…Planned insider sales…Executive pay…Wikipedia attention…SEC enforcement…

About the company

The basics from the company’s SEC registration.

Legal name: Cardiol Therapeutics Inc.
Address: 602-2265 UPPER MIDDLE ROAD EAST, OAKVILLE, Ontario, Canada L6H 0G5
Phone: 289-910-0850
Fiscal year ends: Dec 31
Filer category: emerging growth company
Incorporated in: Ontario, Canada
Listed as: CRDL (Nasdaq)
SEC filings: All filings on SEC EDGAR ↗

About the company

The basics from the company’s SEC registration.

Loading…

$1.00−$0.04 (−3.85%) Nov 13 close

1M3M1Y

Oct 13, 2026Low $0.9265 · High $1.20Nov 13, 2026

Aug 13, 2026Low $0.9265 · High $2.29Nov 13, 2026

Nov 13, 2025Low $0.926 · High $2.29Nov 13, 2026

Congress purchase Congress sale Insider sale over $1M

Adjusted for stock splits; not for dividends. Where prices come from.

Live chart

Intraday and historical prices from TradingView. Quotes may be delayed.

Loading chart…

Information, not investment advice. Company matching is automatic; check the source before relying on one row.